Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Monopar Therapeutics Inc.: Monopar and NorthStar Amend & Extend Collaboration | 2 | GlobeNewswire (USA) | ||
10.06. | Monopar Therapeutics Inc.: Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting | 2 | GlobeNewswire (USA) | ||
24.05. | Monopar Therapeutics Inc.: Monopar Announces CFO Succession | 107 | GlobeNewswire (Europe) | WILMETTE, Ill., May 24, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
09.05. | Monopar Therapeutics Inc.: Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline | 143 | GlobeNewswire (Europe) | Initiated MNPR-101-Zr First-in-Human Phase 1 Radiopharma Clinical Trial MNPR-101-RIT Phase 1 Clinical Trial Targeted for Launch as Early as Q4 2024 or Q1 2025 WILMETTE, Ill., May 09, 2024 (GLOBE NEWSWIRE)... ► Artikel lesen | |
18.04. | Monopar Therapeutics Inc.: Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting | 2 | GlobeNewswire (USA) | ||
10.04. | Monopar Therapeutics Inc.: Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients | 402 | GlobeNewswire (Europe) | WILMETTE, Ill., April 10, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
28.03. | Monopar Therapeutics Inc reports results for the quarter ended in December - Earnings Summary | 3 | Reuters | ||
28.03. | Monopar Therapeutics Inc.: Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments | 91 | GlobeNewswire (Europe) | WILMETTE, Ill., March 28, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
05.03. | Monopar Therapeutics Inc.: Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program | 142 | GlobeNewswire (Europe) | WILMETTE, Ill., March 05, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
27.02. | Monopar Therapeutics Inc.: Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial | 279 | GlobeNewswire (Europe) | WILMETTE, Ill., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
20.02. | Monopar Therapeutics Inc.: Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers | 313 | GlobeNewswire (Europe) | WILMETTE, Ill., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 4.118 |
NVIDIA | 2.920 |
TUI | 2.281 |
GAMESTOP | 2.174 |
BAYER | 1.701 |
NEL | 1.645 |
RHEINMETALL | 1.432 |
BYD | 1.258 |
DEUTSCHE LUFTHANSA | 1.115 |
TESLA | 871 |
VOLKSWAGEN | 792 |
CARL ZEISS MEDITEC | 679 |
APPLE | 660 |
BASF | 637 |
SUPER MICRO COMPUTER | 631 |
SNOWFLAKE | 605 |
AIXTRON SE | 596 |
COMMERZBANK | 594 |
DEFI TECHNOLOGIES | 592 |
THYSSENKRUPP | 590 |
PORSCHE SE | 573 |
CAVENDISH HYDROGEN | 527 |
DEUTSCHE BANK | 503 |
MERCEDES-BENZ | 498 |
ALLIANZ | 488 |